Clotilde Guidetti | Neuropharmacology | Best Researcher Award

Posted on by Neuroscientists

Dr. Clotilde Guidetti | Neuropharmacology | Best Researcher Award

Dr. Clotilde Guidetti, Harvard Medical School, Massachusetts General Hospital, United States.

Clotilde Guidetti is an accomplished early-career physician-scientist specializing in Child and Adolescent Neuropsychiatry. With a classical foundation and medical training from the University of Genoa, she excelled academically, earning multiple merit awards and graduating Summa Cum Laude. She completed her specialized residency at the Catholic University of Rome, further refining her clinical expertise. Clotilde’s research focus lies in neurodevelopmental disorders, behavioral interventions, and psychopharmacology in pediatric populations. She has already demonstrated promise as an independent researcher through competitive grant submissions and award-winning conference presentations. Based in Boston, she is actively shaping a career that bridges clinical care and scientific innovation.

Profile

Scopus

 

🎓 Early Academic Pursuits

Clotilde Guidetti began her academic journey with a deep-rooted passion for understanding the human mind and behavior. She earned her High School Diploma in Classical Studies from the prestigious State High School Andrea D’Oria, an early indication of her strong intellectual curiosity and dedication to learning. This foundation in classical education provided her with a broad humanistic perspective that continues to inform her clinical and research approach. She then pursued her Medical Degree at the University of Genoa, where she graduated Summa Cum Laude in 2020. Her academic record was consistently marked by distinction, earning multiple Academic Merit Awards for clinical excellence during her medical studies.

🧠 Professional Endeavors

Following her graduation, Dr. Guidetti further specialized in the field of Child and Adolescent Neuropsychiatry through a rigorous residency program at the Catholic University of Rome. Completed in November 2024, her residency was also distinguished with Summa Cum Laude honors, reflecting both her clinical acumen and compassionate engagement with young patients. Her professional training combined intensive clinical work with scholarly research, preparing her to address complex neurodevelopmental and psychiatric disorders in children and adolescents.

🔬 Contributions and Research Focus

Dr. Guidetti’s primary research interests lie at the intersection of neurodevelopment, behavioral disorders, and psychopharmacology in pediatric populations. Her clinical insights are deeply enriched by her scientific inquiries, particularly those focused on the early diagnosis and personalized treatment of neuropsychiatric conditions. She has already begun shaping her independent research path, as seen in her recent submission for the Brain & Behavior Research Foundation Young Investigator Grant in January 2025. Her project, currently under review, reflects her growing reputation as an emerging scholar in the domain of pediatric neuropsychiatry.

🏅 Accolades and Recognition

Throughout her academic and clinical journey, Clotilde Guidetti has been the recipient of multiple honors that highlight her outstanding abilities. These include three Academic Merit Awards from the University of Genoa and a prestigious Erasmus Socrates Fellowship in 2017–2018, which broadened her training in an international context. In 2022, she received the Attilio Sabato Award from the Società Italiana di Neuropsicofarmacologia (SINPF) for the best poster presentation—an achievement that not only celebrated her communication skills but also her innovative scientific thinking in neuropsychopharmacology.

🌍 Impact and Influence

Though early in her career, Dr. Guidetti has already begun to leave a meaningful mark on the field of child and adolescent mental health. Her dual focus on clinical excellence and academic inquiry ensures that her work resonates both within medical communities and in the lives of the families she serves. With a practice grounded in empathy and scientific rigor, she exemplifies the new generation of clinician-scientists committed to transforming mental health care for the most vulnerable populations.

🧬 Legacy and Future Contributions

As she looks to the future, Clotilde Guidetti aims to expand her contributions to academic psychiatry through collaborative research, cross-disciplinary studies, and the mentorship of emerging professionals in the field. Her continued involvement in national and international research networks promises to amplify her influence, paving the way for innovative treatments and holistic models of care in pediatric neuropsychiatry. Her vision is firmly centered on early intervention, neurodevelopmental resilience, and the integration of clinical practice with cutting-edge neuroscience.

📚 Academic Footprint

Dr. Guidetti currently resides and practices in Boston, Massachusetts, where she continues to build her clinical and research profile. Her dual base—rooted in Italy and expanding into the United States—places her at the nexus of transatlantic collaboration. With each project and presentation, she further refines her expertise and extends her academic footprint, fostering a dynamic career defined by global engagement, intellectual integrity, and unwavering commitment to child and adolescent mental health.

Publication

  • Title: Antidepressants in the acute treatment of post-traumatic stress disorder in adults: a systematic review and meta-analysis

  • Authors: Guidetti, Clotilde; Feeney, Anna; Hock, Rebecca S.; Fava, Maurizio; Papakostas, George I.

  • Year: 2024

 

📝 Conclusion

Dr. Guidetti embodies the ideal of a compassionate clinician and rigorous academic, poised to make significant contributions to the future of child and adolescent mental health. Her career so far reflects a seamless blend of scholarly excellence, clinical sensitivity, and a drive to push the boundaries of understanding in neuropsychiatry. As she continues to expand her research and collaborative efforts globally, her work promises to influence both scientific discourse and practical approaches in mental health care—building a legacy rooted in evidence, empathy, and innovation.

 

Gilles Rode | Clinical Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Prof. Gilles Rode | Clinical Neuroscience | Best Researcher Award

Dr. Gilles Rode is a distinguished figure in the field of Physical Medicine and Rehabilitation (PMR), holding significant positions at both academic and clinical institutions in France. His career spans decades, with a strong foundation built on his dual M.D. and Ph.D., which paved the way for his pioneering work in neuroplasticity and motor rehabilitation. As the Head of the Department of Rehabilitation at Hôpital Henry Gabrielle and the Dean of the Faculty of Medicine Lyon-Est, he has contributed extensively to the development of rehabilitation practices, medical education, and research. Dr. Rode’s research focuses on understanding neurological recovery and enhancing rehabilitation techniques for patients with brain injuries, while his leadership roles in organizations like the French Society of Physical Medicine and Rehabilitation (Sofmer) and the European Academy of Rehabilitation and Physical Medicine underscore his impact on a global scale.

Profile

Scopus

 

Early Academic Pursuits 📚


Gilles Rode’s academic journey began with a strong foundation in medicine and physical rehabilitation, which led him to pursue a dual M.D. and Ph.D. This unique combination of clinical and scientific expertise laid the groundwork for his exceptional career. His training at esteemed institutions in France, particularly at Université Claude Bernard Lyon 1, has enabled him to delve deeply into the complexities of physical medicine and rehabilitation (PMR). It was during this phase that Dr. Rode developed an interest in combining clinical work with cutting-edge research, exploring the rehabilitation processes from both medical and scientific perspectives.

Professional Endeavors 🏥


In his professional career, Dr. Rode has held pivotal roles in both clinical and academic settings. Since 2009, he has served as the Head of the Department of Rehabilitation at Hôpital Henry Gabrielle, part of the Hospices Civils de Lyon. This role allowed him to shape the development of rehabilitation practices within a leading French hospital. Furthermore, between 2009 and 2016, he contributed significantly as the Vice-Dean at the Faculty of Medicine Lyon-Est, Université Claude Bernard Lyon 1, a position that gave him a platform to influence medical education. His leadership and vision have consistently propelled the field forward, particularly in the integration of advanced rehabilitation techniques into patient care.

Contributions and Research Focus 🔬

Dr. Rode’s research has consistently focused on enhancing physical rehabilitation methods, particularly for individuals recovering from neurological impairments. His scientific inquiries are centered on understanding the mechanisms of neuroplasticity and recovery in brain-injured patients. As a leading member of the Centre de Recherche en Neurosciences de Lyon, his work integrates neuroscience with rehabilitation science, aiming to improve clinical practices and outcomes. His pioneering studies on motor rehabilitation and the use of innovative techniques for brain injury recovery have earned him recognition within both the scientific and medical communities.

Accolades and Recognition 🏅


Dr. Rode’s commitment to advancing the field of physical medicine and rehabilitation has been recognized through numerous accolades. He served as the President of the French Society of Physical Medicine and Rehabilitation (Sofmer) from 2013 to 2016, a position that allowed him to advocate for the integration of contemporary rehabilitation approaches in French healthcare. In 2015, he was elected as a member of the European Academy of Rehabilitation and Physical Medicine, further cementing his status as a leader in the field. His leadership roles and scientific contributions have earned him significant recognition both nationally and internationally.

Impact and Influence 🌍


Dr. Rode’s impact extends far beyond his clinical and academic roles. His work has influenced policies in rehabilitation medicine and has set standards for how rehabilitation should be practiced in hospital settings. As the Dean of the Faculty of Medicine Lyon-Est, he has been at the forefront of shaping medical curricula to ensure that the next generation of doctors is well-equipped to address the challenges of rehabilitation medicine. His ability to bridge the gap between research and clinical practice has resulted in more effective therapies and patient outcomes, impacting countless lives.

Legacy and Future Contributions 🔮


As Dr. Rode continues his work, his legacy is one of both clinical excellence and scientific innovation. His research has had a lasting effect on how physical medicine and rehabilitation are perceived in the medical community. Moving forward, Dr. Rode is expected to continue influencing the development of rehabilitation therapies, particularly in the areas of neuroplasticity and motor recovery. His future contributions will undoubtedly build on the foundation he has established, ensuring that patients continue to benefit from the evolving advancements in rehabilitation medicine.

Global Influence and Leadership 🌐


Dr. Rode’s reputation extends beyond the borders of France, as he is often invited to share his expertise at international conferences and seminars. His leadership in both academia and professional societies has made him a global voice in rehabilitation. Through his active involvement in the European Academy of Rehabilitation and Physical Medicine, he continues to contribute to the global exchange of ideas, driving the evolution of rehabilitation practices across Europe and beyond. Dr. Rode’s influence is not just felt in France but is also shaping the future of rehabilitation medicine worldwide.

Publication

  • Title: Determining the influence of a sleep improvement intervention on medical students’ sleep and fatigue: protocol of the PROMESS-Sleep clinical trial
    Authors: Ruet, Axelle; Ndiki Mayi, Evrard Florentin; Métais, Angèle; Rode, Gilles; Schlatter, Sophie T.
    Year: 2025

 

  • Title: Determining the influence of an intervention of stress management on medical students’ levels of psychophysiological stress: the protocol of the PROMESS-Stress clinical trial
    Authors: Métais, Angèle; Omarjee, Mohammad; Valero, Bérénice; Rode, Gilles; Schlatter, Sophie T.
    Year: 2025

 

  • Title: Co-administration of methylphenidate and prism adaptation would require striatal integrity to alleviate spatial neglect: A preliminary study
    Authors: Beaudoin-Gobert, Maude; Benistant, Faustine; de Lanversin, Maxence; Rossetti, Yves; Luauté, Jacques
    Year: 2024 (presumed, not listed but grouped contextually)

 

  • Title: Updates on post-stroke rehabilitation
    Authors: Charbonnier, Geoffroy; Bihel, Lucie; Jacquin-Courtois, Sophie; Rode, Gilles; Mateo, Sébastien
    Year: 2024 (presumed)

 

  • Title: Effect of coping interventions on performance of medical students during objective structured clinical examination: A randomized controlled trial
    Authors: Schlatter, Sophie T.; Berland, Alexandre; Lutz, Antoine; Rode, Gilles; Lilot, Marc E.
    Year: 2025

 

  • Title: Associations of coping and health-related behaviors with medical students’ well-being and performance during objective structured clinical examination
    Authors: Barret, Noémie; Guillaumée, Théodore; Rimmelé, Thomas R.; Lilot, Marc E.; Schlatter, Sophie T.
    Year: 2024

 

  • Title: Grasping rehabilitation using motor imagery with or without neurofeedback after tetraplegia: A study protocol for a bicentric randomised controlled trial
    Authors: Charbonnier, Geoffroy; Reilly, Karen T.; Schwartz, Denis P.; Rode, Gilles; Mateo, Sébastien
    Year: 2024

 

  • Title: Neck muscle vibration and prism adaptation fail to improve balance disturbances after stroke: A multicentre randomised controlled study
    Authors: Leplaideur, Stephanie; Allart, Etienne; Chochina, Lucie; Bannier, Élise; Bonan, Isabelle Véronique
    Year: 2024

 

  • Title: Striking the Balance: Embracing Technology While Upholding Humanistic Principles in Neurorehabilitation
    Authors: Ardaillon, Hugo; Ribault, Shams; Herault, Caroline; Reilly, Karen T.; Rode, Gilles
    Year: 2024

 

  • Title: Implicit and explicit motor imagery ability after SCI: Moving the elbow makes the difference
    Authors: Mateo, Sébastien; Guillot, Aymeric; Henkous, Sonia; Collet, Christian; Di Rienzo, Franck
    Year: 2024

 

Conclusion


Dr. Gilles Rode’s work has left an indelible mark on the field of rehabilitation, where his contributions have influenced both clinical practices and academic curricula. His dedication to improving patient outcomes through innovative rehabilitation methods, combined with his leadership and advocacy in professional societies, ensures that his influence will continue for years to come. As he progresses in his career, Dr. Rode remains a key figure in advancing the field of physical medicine and rehabilitation, shaping both the future of patient care and the next generation of healthcare professionals. His legacy will continue to inspire progress in rehabilitation science, benefiting countless individuals across the globe.

Handrean Soran | Clinical Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Prof. Handrean Soran | Clinical Neuroscience | Best Researcher Award

Prof. Handrean Soran,  Manchester University NHS Foundation Trust, United Kingdom.

Dr. Handrean Soran is a distinguished British endocrinologist and researcher with expertise in diabetes, endocrinology, and cardiovascular diseases. His academic journey began in Iraq and advanced through the UK, where he earned prestigious medical qualifications, including an MD in Medicine and MSc in Diabetes and Endocrinology. Throughout his career, Dr. Soran has contributed significantly to research on the relationship between diabetes and cardiovascular health, publishing extensively in high-impact journals like The New England Journal of Medicine and Lancet. His work has garnered global recognition, including an H-index of 49 and numerous accolades, solidifying his position as a leader in his field.

Profile

Google Scholar

 

Early Academic Pursuits 📚

Handrean Soran’s academic journey began in the Kurdistan region of Iraq, where he completed his A-levels with an impressive score of 94.5% from Sulemani High School in 1985. His drive for knowledge led him to pursue his MBChB at Al-Mustansyria University in Baghdad, Iraq, graduating in 1990. This foundational education set the stage for a career dedicated to medical research and practice. After completing his medical degree, he pursued further specialized training in the UK, where he earned his MRCP from the Royal College of Physicians in Edinburgh in 1999, and later, an MSc in Diabetes and Endocrinology from the University of Liverpool in 2006. These early academic milestones laid the foundation for his later expertise in endocrinology and diabetes, fields that would define his career.

Professional Endeavors 🏥

Dr. Handrean Soran’s professional journey is marked by a dedication to medicine, particularly in the fields of endocrinology and diabetes. He has held significant roles in prestigious institutions, with his current position in the Department of Diabetes, Endocrinology, and Metabolism at Manchester University Hospitals NHS Foundation Trust. His medical career was further enhanced by his qualifications as a Fellow of the Royal College of Physicians (FRCP) from both Glasgow and Edinburgh. Throughout his career, Dr. Soran has worked on developing innovative approaches in clinical care and research, constantly striving to improve patient outcomes and advancing medical knowledge.

Contributions and Research Focus 🔬

Dr. Soran’s research focus primarily centers on diabetes, endocrinology, and cardiovascular health, specifically the interplay between metabolic disorders and heart disease. His research efforts have been integral to understanding the link between diabetes and cardiovascular risk, with a significant body of work examining the effects of treatments on these interconnected conditions. His contributions have been recognized through multiple high-impact publications in renowned journals such as the New England Journal of Medicine, Lancet, and European Heart Journal. With an H-index of 49 and over 130 citations, Dr. Soran’s work continues to shape the clinical landscape in these areas, driving further advancements in treatment protocols and therapeutic strategies for diabetes and cardiovascular diseases.

Accolades and Recognition 🏆

Dr. Soran’s career has been decorated with numerous accolades, affirming his status as a leader in his field. He achieved the prestigious title of Fellow of the Royal College of Physicians (FRCP) in both Edinburgh and Glasgow, a testament to his clinical expertise and contribution to medical science. His groundbreaking work in diabetes and cardiovascular research has earned him recognition not only from peers but also from major medical institutions. His publications in top-tier journals further highlight his academic prowess, solidifying his position as a key thought leader in the medical and academic communities.

Impact and Influence 🌍

Dr. Handrean Soran’s work extends beyond the realm of research publications; it has made a lasting impact on the clinical management of diabetes and cardiovascular diseases worldwide. His insights have contributed to shaping healthcare policies and clinical practices, particularly in the management of diabetic patients at high cardiovascular risk. Through his collaboration with the Division of Cardiovascular Sciences at the University of Manchester, he has fostered interdisciplinary approaches to solving complex medical challenges, advancing the integration of cardiovascular care with endocrinology. His work has influenced not only academic circles but also clinical practice, providing new directions for patient care.

Legacy and Future Contributions 🌱

As Dr. Soran continues his impactful work, his legacy is one of dedication to improving patient health outcomes and advancing the fields of endocrinology and diabetes. With a deep commitment to teaching and mentorship, Dr. Soran plays a pivotal role in training the next generation of doctors and researchers. His future contributions are poised to further explore the intricate relationship between metabolic disorders and cardiovascular health, addressing the growing global burden of these interconnected diseases. His work will undoubtedly continue to guide both clinical practice and future research in endocrinology, diabetes, and cardiovascular medicine, ensuring his ongoing influence in these critical areas.

Global Recognition and Influence 🌐

Dr. Soran’s influence reaches across borders, as evidenced by his extensive publication record and recognition within the global medical community. His research has not only enriched the scientific literature but also contributed to global health initiatives, particularly in the area of metabolic disorders and cardiovascular diseases. With collaborations spanning multiple continents, Dr. Soran is dedicated to improving health outcomes globally, offering expert insights into the prevention and management of diabetes and heart disease. His role in shaping clinical guidelines and his participation in international research collaborations further amplify his global impact.

Academic and Professional Leadership 🎓

In addition to his research contributions, Dr. Soran’s leadership within academia is profound. He holds multiple academic positions, including his affiliation with the University of Manchester, where he plays an integral role in advancing research within the Division of Cardiovascular Sciences. His leadership extends to mentoring young researchers and clinicians, helping to foster a new generation of experts in endocrinology and diabetes. Dr. Soran’s academic vision continues to drive progress in both education and research, making significant strides in improving how diabetes and cardiovascular diseases are understood and treated. His future work promises to leave a lasting mark on medical education and the advancement of scientific knowledge.

Publication

  • Cardiovascular efficacy and safety of bococizumab in high-risk patients
    Author: PM Ridker
    Year: 2017

 

  • Volanesorsen and triglyceride levels in familial chylomicronemia syndrome
    Author: JL Witztum
    Year: 2019

 

  • Triglyceride lowering with pemafibrate to reduce cardiovascular risk
    Author: A Das Pradhan
    Year: 2022

 

  • Diabetes dyslipidemia
    Author: JD Schofield
    Year: 2016

 

  • Lysosomal acid lipase deficiency–an under-recognized cause of dyslipidaemia and liver dysfunction
    Author: Ž Reiner
    Year: 2014

 

  • Obesity: a critical risk factor in the COVID‐19 pandemic
    Author: S Kwok
    Year: 2020

 

  • Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY …
    Author: KK Ray
    Year: 2019

 

  • Hypercholesterolaemia and its management
    Author: D Bhatnagar
    Year: 2008

 

  • Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
    Author: B Williams
    Year: 2018

 

  • Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset …
    Author: FJ Raal
    Year: 2017

 

Conclusion

Dr. Handrean Soran’s career is marked by profound contributions to medical science, particularly in the fields of diabetes and cardiovascular health. His groundbreaking research and clinical expertise have had a significant impact on both academic and healthcare practices worldwide. As a recognized leader in his field, Dr. Soran’s work continues to influence the management of metabolic and cardiovascular diseases, and his future contributions promise to further advance these critical areas of medical research and practice. His legacy is one of dedication, leadership, and a commitment to improving health outcomes globally.

 

Mohammed Hammad Jaber Amin | Cognitive Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Dr. Mohammed Hammad Jaber Amin | Cognitive Neuroscience | Best Researcher Award

Dr. Mohammed Hammad Jaber Amin, Alzaiem Alazhari University, Sudan.

Driven by an unwavering passion for surgery and a deep-rooted interest in radiology and interventional radiology, I am a resilient medical student committed to academic excellence, research innovation, and compassionate service. With hands-on clinical experiences in prestigious institutions and an active role in mentoring students, I blend academic rigor with real-world engagement. My involvement in social initiatives and international exchange programs reflects my holistic approach to medicine—one that bridges science with empathy, and research with community impact. I strive to contribute meaningfully to advancements in medical imaging and minimally invasive techniques, all while fostering a culture of continuous learning and global collaboration.

Profile

Orcid

🎓 Early Academic Pursuits

From the very beginning of my academic journey, I have been guided by an insatiable curiosity and a steadfast determination to explore the depths of human anatomy and healing. My acceptance into medical school was not just an achievement but a defining milestone that symbolized years of perseverance, discipline, and an unyielding resolve to serve humanity. Immersed in the rigorous demands of medical education, I quickly gravitated toward the intricate world of surgery, where precision, empathy, and knowledge converge. My fascination with the ever-evolving realm of radiology and interventional radiology took root early on, driven by a passion to decode the human body through advanced imaging and minimally invasive techniques.

🩺 Professional Endeavors

As a medical student deeply engrossed in surgical sciences, I actively pursue clinical exposure in prestigious institutions like the Mayo Clinic and Hamad Institute. These experiences, under the mentorship of distinguished surgeons and radiologists, are pivotal in refining my practical skills and theoretical knowledge. I am currently seeking international electives and clinical rotations to broaden my medical horizon, embrace diverse healthcare systems, and strengthen my expertise in interventional radiology. These endeavors are not just about technical training but about understanding the holistic patient experience in global contexts.

🧠 Contributions and Research Focus

My immersion in medical research stems from a belief that innovation is born at the intersection of inquiry and compassion. With a special focus on radiology and interventional techniques, I strive to contribute meaningfully to cutting-edge studies that have the potential to revolutionize diagnostics and patient care. My research interests delve into image-guided interventions and the integration of emerging technologies within surgical frameworks. Through dedicated collaboration with peers and mentors, I envision contributing to discoveries that not only enhance procedural efficacy but also reduce patient recovery time and complications.

🏅 Accolades and Recognition

While formal accolades are cherished milestones, I consider the trust and guidance of esteemed mentors and the academic progress of my students as my most valued achievements. Tutoring A-level and O-level students brings me profound joy, especially when I witness their growth in mastering complex concepts and developing crucial time management skills. My active involvement in mentoring is recognized not only within academic circles but also among community organizations, affirming my commitment to empowering the next generation of learners.

🌍 Impact and Influence

Medicine, for me, is not confined to the sterile walls of a hospital—it extends into communities, transcending cultural and geographic boundaries. My active participation in social service programs and international medical exchanges has allowed me to cultivate a deep empathy for underserved populations. Collaborating with initiatives led by the Lions Club and Rotary International has been instrumental in strengthening my social conscience, fostering global medical solidarity, and enhancing the quality of care provided to marginalized communities. These experiences shape my understanding of healthcare as a universal right, not a privilege.

🔬 Legacy and Future Contributions

Looking forward, I envision a future where my contributions to radiology and interventional surgery can catalyze transformative changes in how diseases are diagnosed and treated. I am dedicated to harnessing the power of interdisciplinary research to bridge existing gaps in global health equity. My goal is to pioneer minimally invasive diagnostic techniques that are both accessible and effective, especially in low-resource settings. Beyond the laboratory and clinic, I aspire to mentor aspiring physicians, sharing not just knowledge but a vision of medicine rooted in compassion, ethics, and relentless innovation.

Publication

  • Title: Prevalence of cognitive dysfunction and associated behavioral changes, lactational failure, and their determinants among postpartum women in South India: A community‐based study
    Authors: Sakshi Kumari; Raghavendraswamy Koppad; Arashdeep Singh; Boentika Singh; Muhammad Saeed Qazi; Mohammed Hammad Jaber Amin
    Year: 2025

 

  • Title: Risk Factors and Pharmacological Interventions Impacting Cerebrovascular Ischemic Events in Giant Cell Arteritis: A Narrative Review
    Authors: Muhammad Osama Siddiqui; Mohammad Ali Syed; Ayaan Ahmed Qureshi; Mustafa Hussain Imam; Jatin Motwani; Verkha Kumari; Arooba Siddiqui; Noor Ul Ain; Mohammed Hammad Jaber
    Year: 2025

 

  • Title: Advancements in PNH treatment: crovalimab’s clinical efficacy
    Authors: Eisha Shoaib; Filzah Imam; Mahnoor Khan; Mohammed H. Jaber Amin
    Year: 2024

 

  • Title: Lenmeldy (OTL-200) in MLD: FDA’s validation of advanced therapy
    Authors: Ayaan Ahmed Qureshi; Bakhtawar Shaikh; Aishath Sadha Aswad; Ahmed Hisaan Saeed; Hanfaa Tabassum; Muhammad Fawad Tahir; Muhammed Hammad Jaber
    Year: 2024

 

  • Title: Tarlatamab’s FDA approval: shaping the future of cancer therapy
    Authors: Iqra Alamgir; Unsa Alamgir; Eman Alamgir; Ayaan Ahmed Qureshi; Muhammad Osama Siddiqui; Mohammed Hammad Jaber; Jatin Motwani
    Year: 2024

 

  • Title: Knowledge, attitude, and practice of artificial intelligence among medical students in Sudan: a cross-sectional study
    Authors: Mohammed Hammad Jaber Amin et al.
    Year: 2024

 

  • Title: Risk Factors and Pharmacological Interventions Impacting Cerebrovascular Ischemic Events in Giant Cell Arteritis: A Narrative Review (Preprint)
    Authors: Muhammad Siddiqui; Mohammad Syed; Ayaan Qureshi; Mustafa Imam; Jatin Motwani; Verkha Kumari; Arooba Siddiqui; Noor Ul Ain; Mohammed Hammad Jaber
    Year: 2024

 

  • Title: Assessment of the importance of sleep quality and the effects of deprivation on Sudanese healthcare professionals amidst conflict in Sudan
    Authors: Mohammed Hammad Jaber Amin et al.
    Year: 2024

 

  • Title: Understanding Enterococcus Biofilm: A Path to Targeted Therapy (Preprint)
    Authors: Muhammad Fawad Tahir; Mugdha Tendulkar; Abdul Shah Syed; Laveeza Fatima; Sania Riaz; Fatima Raza; Iqra Haseeb; Reshma Tendulkar; Mohammed Hammad Jaber
    Year: 2024

 

  • Title: Breaking Ground: Lenmeldy’s Approval and the Future of MLD Treatment (Preprint)
    Authors: Ayaan Ahmed Qureshi; Aishath Sadha Aswad; Bakhtawar Shaikh; Ahmed Hisaan Saeed; Hanfaa Tabassum; Muhammad Fawad Tahir; Mohammed Hammad Jaber
    Year: 2024

 

✅ Conclusion

Medicine is not just a career for me—it is a lifelong calling fueled by curiosity, compassion, and commitment. As I continue this journey, I aim to not only excel in my chosen specialties but also to be a catalyst for positive change in the global healthcare landscape. Through dedicated research, international exposure, and social service, I aspire to leave a legacy rooted in innovation, integrity, and impact. The journey is ongoing, and each new day offers a step closer to transforming both individual lives and the broader future of medicine.

Arpana Church | Social and Cultural Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Dr. Arpana Church | Social and Cultural Neuroscience | Best Researcher Award

Dr. Arpana Church, University of California Los Angeles, United States.

Dr. Arpana Church (P.K.A. Gupta, Arpana, Ph.D.) is a distinguished scientist and researcher based at the David Geffen School of Medicine, UCLA. Her academic path began with a Bachelor’s degree in 1998 and evolved into a dynamic career centered on the gut-brain-microbiome connection. With professional appointments at the UCLA Goodman Luskin Microbiome Center and the Oppenheimer Center for Neurobiology of Stress and Resilience, Dr. Church plays a pivotal role in advancing research related to stress, digestive health, metabolic disorders, and behavioral conditions. Her scientific contributions bridge disciplines, offering innovative insights into how microbiota influence both emotional and physical well-being. She is recognized for her leadership, collaborative spirit, and commitment to shaping future research directions in microbiome science and neurogastroenterology.

Profile

Google Scholar

 

🎓 Early Academic Pursuits

Dr. Arpana Church’s academic journey began with a solid foundation in the sciences, earning her Bachelor’s degree in 1998. With an innate curiosity for the biological underpinnings of health and disease, she embarked on a rigorous academic trajectory that would eventually culminate in a Ph.D. Her early academic pursuits were characterized by a strong commitment to multidisciplinary learning, laying the groundwork for her future focus on microbiome research and neurogastroenterology. These formative years not only refined her scientific thinking but also ignited her passion for translational research, bridging laboratory insights with clinical outcomes.

🧠 Professional Endeavors in Neuroscience & Gut-Brain Axis

Currently, Dr. Church serves at the prestigious UCLA Goodman Luskin Microbiome Center and the G. Oppenheimer Center for Neurobiology of Stress and Resilience. Her role spans across several key initiatives, including the Obesity, Metabolic Disorders and Eating Behaviors Research Program, all housed within the David Geffen School of Medicine at UCLA. Her work within the Vatche and Tamar Manoukian Division of Digestive Diseases exemplifies her commitment to exploring how brain–gut–microbiome interactions influence metabolic and behavioral outcomes. Her professional life is immersed in academic medicine, where she actively contributes to cutting-edge clinical research and institutional growth.

🔬 Contributions and Research Focus

Dr. Church’s research is at the intersection of microbiome science, stress neurobiology, and gastrointestinal health. She is a key contributor to studies investigating the gut–brain axis, particularly how microbiota affect emotional, cognitive, and metabolic health. Her innovative work explores mechanisms of resilience and vulnerability in the face of chronic stress, offering critical insights into conditions such as obesity, irritable bowel syndrome (IBS), and eating disorders. Through her role at UCLA, she is deeply involved in collaborative projects that combine advanced imaging, biomarker analysis, and behavioral science to unravel complex biological pathways.

🏆 Accolades and Recognition

While the document doesn’t detail specific awards, Dr. Church’s professional affiliation with UCLA and her active role in multiple research centers reflect a high level of peer recognition. Her expertise and leadership in high-impact research programs speak to her standing in the academic and clinical communities. She is frequently sought after for collaborative projects and research consultations, evidencing the respect she commands in the field of medical science and integrative health.

🌍 Impact and Influence

Dr. Church’s work has meaningful implications on both scientific knowledge and public health. Her research on stress and digestive health not only contributes to academic literature but also informs clinical interventions that improve quality of life for patients. Through mentorship and active participation in interdisciplinary research teams, she is shaping the next generation of scientists and physicians. Her influence extends beyond the lab and into broader discussions on the role of the microbiome in mental and metabolic health.

🧬 Legacy and Future Contributions

As science continues to uncover the profound links between the brain, gut, and microbiome, Dr. Arpana Church stands poised to be at the forefront of this revolution. Her future contributions will likely expand into precision medicine and integrative approaches that personalize treatment strategies based on microbiome and neurobiological profiles. With a vision grounded in holistic health and a career rooted in academic excellence, her legacy will be one of transformation—redefining how we understand and treat complex diseases of the mind and body.

Publication

  • Racism as a Determinant of Health: A Systematic Review and Meta-Analysis
    Y Paradies, J Ben, N Denson, A Elias, N Priest, A Pieterse, A Gupta, …
    2015

 

  • Gut/brain axis and the microbiota
    EA Mayer, K Tillisch, A Gupta
    2015

 

  • Examining the relationship between multiple internalized oppressions and African American lesbian, gay, bisexual, and questioning persons’ self-esteem and psychological distress
    DM Szymanski, A Gupta
    2009

 

  • The “model minority myth”: Internalized racialism of positive stereotypes as correlates of psychological distress, and attitudes toward help-seeking
    A Gupta, DM Szymanski, FTL Leong
    2011

 

  • Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome
    JS Labus, EB Hollister, J Jacobs, K Kirbach, N Oezguen, A Gupta, …
    2017

 

  • Brain–gut–microbiome interactions in obesity and food addiction
    A Gupta, V Osadchiy, EA Mayer
    2020

 

  • Influence of early life, diet, and the environment on the microbiome
    TS Dong, A Gupta
    2019

 

  • Gut Microbiome and Obesity: A Plausible Explanation for Obesity
    C Sanmiguel, A Gupta, EA Mayer
    2015

 

  • Attitudes toward professional counseling among Asian-American college students: Acculturation, conceptions of mental illness, and loss of face
    FTL Leong, HHW Kim, A Gupta
    2011

 

  • Internalized misogyny as a moderator of the link between sexist events and women’s psychological distress
    DM Szymanski, A Gupta, ER Carr, D Stewart
    2009

 

📝 Conclusion

Dr. Arpana Church’s career is a testament to the power of interdisciplinary research in uncovering the biological basis of complex health issues. Her work not only deepens our understanding of the brain–gut connection but also paves the way for new diagnostic and therapeutic strategies. Rooted in academic excellence and driven by a passion for discovery, she continues to inspire through her contributions to science, medicine, and mentorship. As microbiome and neurobiology research gain momentum globally, Dr. Church remains a vital force in shaping the future of integrative health research and translational medicine.

FAZLI MAULA | Mycology | Best Researcher Award

Posted on by Neuroscientists

Mr. FAZLI MAULA | Mycology | Best Researcher Award

Mr. FAZLI MAULA, Quaid I Azam university Islamabad, Pakistan.

Fazli Maula is a promising young researcher in the field of Plant Sciences, specializing in fungal taxonomy and environmental studies. With a B.S. in Botany from the University of Swabi and an M.Phil. in Plant Sciences from Quaid-i-Azam University, Islamabad, his academic and research path reflects a deep commitment to biodiversity and ecological health. His notable contributions include the discovery and classification of eleven new mushroom species in District Swabi, as well as research on the environmental and health impacts of tobacco curing practices in Pakistan. Skilled in molecular analysis, fieldwork, and scientific software tools, Fazli has already published and submitted multiple papers to international journals, signaling his early success and potential in biological sciences.

 

Profile

Google Scholar

 

🌱 Early Academic Pursuits

Fazli Maula embarked on his academic journey with a strong passion for plant sciences, earning his Bachelor of Science in Botany from the University of Swabi, Khyber Pakhtunkhwa, Pakistan (2017–2021). During this foundational phase, he cultivated a deep interest in the interaction between plants, human activities, and environmental sustainability. His BS thesis, focused on the ecological and health impacts of tobacco curing practices, reflected a strong inclination towards applied environmental research. Building upon this interest, Fazli pursued an M.Phil. in Plant Sciences at Quaid-i-Azam University, Islamabad, where he delved deeper into the world of fungi and plant taxonomy. His educational path showcases not only academic excellence but also a clear direction toward impactful biological research.

🍄 Research Focus and Contributions

As a Masters Research Fellow at Quaid-i-Azam University (2022–2024), Fazli Maula’s research took a significant leap forward with his thesis titled “Taxonomic evaluation of mushrooms of District Swabi, Khyber Pakhtunkhwa, Pakistan based on their Morphological, Anatomical and Molecular perspectives.” His intensive field surveys during the rainy season led to the collection and classification of diverse mushroom species. Integrating classical taxonomy with modern molecular tools such as ITS and LSU sequencing, Fazli successfully identified eleven new species and three new records for Pakistan—several of which have been published in esteemed international journals. His contribution is pivotal in enriching the mycological biodiversity database of the region, offering new insights into fungal taxonomy.

🔬 Professional Endeavors and Technical Proficiency

Throughout his research journey, Fazli has demonstrated mastery over a range of laboratory and analytical techniques. His expertise encompasses DNA extraction, microscopic analysis, and phylogenetic tree construction using platforms like MEGA and CIPRES. Additionally, he has honed his skills in scientific documentation and visualization using software such as BioEdit, Microsoft Office, Adobe Illustrator, Adobe Photoshop, and other digital tools like PhotoScape and Peximetre. His BS-level work also involved statistical analysis using SPSS, along with field surveys and data collection related to forest depletion and public health, showcasing his versatility in both environmental and microbiological research settings.

📚 Academic Publications and Recognition

Fazli Maula’s research contributions have not gone unnoticed. The groundbreaking nature of his mushroom taxonomy work led to publications in impact factor journals, while his undergraduate study on tobacco-related forest degradation was accepted for publication in October 2024. These early accomplishments are remarkable for a young researcher and reflect his commitment to advancing science that addresses both biodiversity and human health. His ability to publish at this stage in his career stands as a testament to the relevance and quality of his work.

🌍 Societal Impact and Influence

Through his M.Phil. and BS research, Fazli Maula has spotlighted critical environmental and public health issues. His exploration of forest depletion due to tobacco curing underscores the delicate balance between agriculture and sustainability, while his mycological work enhances the understanding of fungal diversity in Pakistan. By merging local ecological research with global scientific standards, Fazli is contributing meaningfully to conservation strategies and sustainable land-use planning in his region.

🧭 Vision and Future Contributions

With a strong foundation in plant sciences and a focused trajectory in fungal taxonomy and environmental health, Fazli Maula is poised for an impactful career in biological research. He envisions further exploration into fungal genomics and bioactive compounds with potential medicinal and ecological significance. His future contributions are expected to bridge the gap between traditional biodiversity documentation and cutting-edge molecular biology, offering solutions to ecological degradation and enriching scientific databases globally.

🏆 Legacy in the Making

Though early in his career, Fazli Maula is building a legacy rooted in curiosity, discipline, and a profound respect for nature’s intricacies. From uncovering new species of mushrooms to addressing ecological consequences of agricultural practices, his work lays the groundwork for future ecological and taxonomic studies in Pakistan. As he continues to expand his research horizons, Fazli’s legacy will likely inspire a new generation of scientists to explore, protect, and understand the hidden layers of biodiversity.

Publication

  • Title: Fungal Planet description sheets: 1614–1696
    Authors: —
    Year: 2024

 

  • Title: Lentinus punjabensis (Polyporaceae), a new species from Lal Suhanra National Park, southern Punjab, Pakistan
    Authors: M. Asif, M. Saba, F. Maula, M. Raza
    Year: 2024

 

  • Title: Taxonomic and phylogenetic evidence reveal a new species and a new record of the genus Marasmius (Marasmiaceae) from Pakistan
    Authors: M. Asif, F. Maula, M. Saba, W. Akram, M. Raza
    Year: 2024

 

  • Title: Integrated morphological and molecular approaches unveil a new species and a new record of the genus Entoloma (Entolomataceae) from southern Punjab
    Authors: M. Asif, M. Saba, W. Akram, F. Maula, M. Raza
    Year: 2024

 

  • Title: Integrative taxonomy and multigene phylogeny uncover three novel taxa of the genus Clitopilus from southern Punjab, Pakistan
    Authors: M.R. M. Asif, M. Saba, W. Akram, F. Maula, F. Ullah, M. Batool, M. Ullah, I.K. Greilhuber
    Year: 2025

 

  • Title: Forest depletion and health hazards: Assessing the environmental and human impacts of tobacco curing practices in Punjab and Khyber Pakhtunkhwa Pakistan
    Authors: W.A.K. Fazli Maula, Zaman Sher, Muhammad Asif, Malka Saba
    Year: 2025

 

  • Title: Taxonomic and phylogenetic evidence reveal a new species of the genus Agaricus section Minores from Pakistan
    Authors: M.B.A.K. Fazli Maula, M. Saba, M. Asif, W. Akram
    Year: 2025

 

  • Title: Multilocus phylogeny contributes to fungal taxonomy with three novel species of Conocybe (Bolbitiaceae) from southern Punjab, Pakistan
    Authors: A.K.M.R. Muhammad Asif, Malka Saba, Fazli Maula, Wajahat Akram
    Year: 2025

 

  • Title: Combined morphological and molecular approaches reveal Conocybe pakistanensis (Bolbitiaceae), a novel species from Punjab, Pakistan
    Authors: A.K.A.N. Wajahat Akram, Malka Saba, Muhammad Asif, Fazli Maula, Momal Batool
    Year: 2025

 

  • Title: Tubaria asiatica (Tubariaceae), a new species from Khyber Pakhtunkhwa, Pakistan
    Authors: F. Maula, M. Saba, M. Asif, W. Akram
    Year: 2025

 

 

🧾 Conclusion

Fazli Maula’s journey is a blend of academic excellence, technical expertise, and a passion for ecological discovery. His work not only contributes to scientific knowledge but also addresses real-world environmental issues affecting forests and communities. With a clear research direction and a growing list of accomplishments, Fazli is set to make lasting contributions in the areas of fungal biodiversity, conservation, and environmental sustainability. His dedication, innovation, and scientific rigor position him as a rising figure in the field of plant and fungal sciences.

Baoying Huang | Pathogen Biology | Best Researcher Award

Posted on by Neuroscientists

Baoying Huang | Pathogen Biology | Best Researcher Award

Ms. Baoying Huang,  National Institute for Viral Disease Control and Prevention, China.

Dr. Baoying Huang, a distinguished professor at the Biotech Center for Viral Disease Emergency, China CDC, has over two decades of experience in combating viral diseases. Her expertise lies in vaccine and antiviral drug development for emerging and re-emerging infectious diseases, including COVID-19, monkeypox, and other human coronaviruses.

 

profile

Scopus

🎓 Education Experience

2008.09–2011.07: Doctor of Medicine, Pathogen Biology,Biotech Center for Viral Disease Emergency, China CDC.2005.09–2008.07: Master of Biology, Pathogen Biology,Biotech Center for Viral Disease Emergency, China CDC. 2001.09–2005.07: Bachelor of Biology,
Life Science Department, Nan Hua University, China.

👩‍🔬 Professional Experience

2020.07–Present:  Professor, China CD ,Focus: Vaccine and antiviral drug R&D for SARS-CoV-2 and poxvirus diseases, including COVID-19 and monkeypox. Key Role: Participated in COVID-19 Emergency Projects for SARS-CoV-2 variant monitoring in China.2015.07–2020.07:  Associate Professor, China CDC. Focus: Vaccine and antiviral drug R&D for emerging infectious diseases like influenza and coronaviruses (SARS-CoV, MERS-CoV).2015.04–2015.06:  Assistant Professor, China CDC. Global Health Support Program: Worked in Sierra Leone to establish Ebola lab systems, improving public health infrastructure.2011.07–2015.07: Assistant Professor, China CDC. Focus: Pathogenic molecular mechanisms of influenza viruses, pseudo-virus applications, and gene-engineered vaccines. 2005.09–2011.07:  Graduate Researcher, IVDC, China CDC. Specialization: Developing universal influenza vaccines for cross-protection against various strains.

🔬 Research Focus

Baoying Huang’s work is dedicated to:Vaccine Development: COVID-19 vaccines (BBIBP-CorV, mRNA vaccines) and pan-orthopoxvirus solutions.Emerging Diseases: Countermeasures for SARS-CoV-2, monkeypox, and other viral threats.Diagnostics: Whole-genome sequencing and real-time PCR for virus detection and monitoring.Therapeutics: Screening novel antivirals targeting viruses like SARS-CoV-2 and monkeypox.Key achievements include:Leading the development of Sinopharm COVID-19 vaccine, later approved by WHO for Emergency Use Listing.Establishing monitoring systems for SARS-CoV-2 variants and assessing their impact on public health measures. Advancing monkeypox vaccine research and identifying promising antiviral compounds against orthopoxviruses.

📚 Publications

  • Title: Molecular architecture of monkeypox mature virus
    • Authors: Hong, Y., Huang, B., Zhang, J., Tan, W., Li, S.
    • Year: 2024

 

  • Title: Vaccinia virus Tiantan strain blocks host antiviral innate immunity and programmed cell death by disrupting gene expression
    • Authors: Wu, C., Zhang, Z., Li, Z., Deng, Y., Tan, W.
    • Year: 2024

 

  • Title: A clinically used anti-human papilloma virus agent (3-hydroxyphthalic anhydride-modified bovine β-lactoglobulin) has a potential for topical application to prevent sexual transmission of monkeypox virus
    • Authors: Sha, Y., Huang, B., Hua, C., Tan, W., Jiang, S.
    • Year: 2024

 

  • Title: Development of a multiplex real-time PCR assay for the simultaneous detection of mpox virus and orthopoxvirus infections
    • Authors: Fan, Z., Xie, Y., Huang, B., Tan, W., Guo, F.
    • Year: 2024

 

  • Title: Accurate determination of the whole genome sequencing and open reading frames composition of non-replicating Tiantan strain of vaccinia virus based on novel long read sequencing platform
    • Authors: Zhang, Z., Wu, C., Li, H., Huang, B., Tan, W.
    • Year: 2024

 

  • Title: Characterization of whole genomes from recently emerging Mpox cases in several regions of China, 2023
    • Authors: Wu, C., Cui, L., Pan, Y., Wang, Q., Tan, W.
    • Year: 2024

 

  • Title: Intranasal immunization with single-dose vaccine based on recombinant influenza virus H1N1 expressing the extracellular domain of respiratory syncytial virus G protein induces robust immunity and protection in mice
    • Authors: Han, R., Wang, D., Wang, T., Huang, B., Tan, W.
    • Year: 2024

 

  • Title: Rapid identification of full-length genome and tracing variations of monkeypox virus in clinical specimens based on mNGS and amplicon sequencing
    • Authors: Wu, C., A, R., Ye, S., Lu, J., Tan, W.
    • Year: 2024

 

  • Title: Long-lasting humoral and cellular memory immunity to vaccinia virus Tiantan provides pre-existing immunity against mpox virus in Chinese population
    • Authors: Li, M., Guo, Y., Deng, Y., Gao, G.F., Liu, J.
    • Year: 2024

 

  • Title: Identification of the VP37 pocket of monkeypox virus as a promising target for pan-orthopoxvirus inhibitors through virtual screening and antiviral assays
    • Authors: Huo, S., Wu, L., Huang, B., Xu, Z., Tan, W.
    • Year: 2024

 

Conclusion

Dr. Huang’s career exemplifies unwavering dedication to improving public health through innovation in vaccine development, antiviral research, and diagnostic technologies. Her contributions to tackling global health challenges, such as the COVID-19 pandemic and monkeypox outbreaks, have significantly impacted infectious disease prevention and control worldwide. As viruses continue to evolve, her pioneering work remains a cornerstone in safeguarding global health.